Article
Alcon licenses anti-infective compound
Fort Worth, TX-Alcon Laboratories' affiliate Alcon Manufacturing Ltd. has signed a collaboration and licensing agreement with NovaCal Pharmaceuticals to research, develop, and commercialize NovaCal's novel Aganocide topical compounds to treat bacterial, viral, and fungal infections in the eye, ear, and sinus.
Fort Worth, TX-Alcon Laboratories' affiliate Alcon Manufacturing Ltd. has signed a collaboration and licensing agreement with NovaCal Pharmaceuticals to research, develop, and commercialize NovaCal's novel Aganocide topical compounds to treat bacterial, viral, and fungal infections in the eye, ear, and sinus.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
